Drug Shortage Report for STALEVO
| Report ID | 129753 |
| Drug Identification Number | 02305941 |
| Brand name | STALEVO |
| Common or Proper name | STALEVO |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVODOPA CARBIDOPA ENTACAPONE |
| Strength(s) | 100MG 25MG 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100FCT BO CA |
| ATC code | N04BA |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-12-04 |
| Estimated end date | 2020-12-11 |
| Actual end date | 2020-12-11 |
| Shortage status | Resolved |
| Updated date | 2020-12-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-12-07 | English | Compare |
| v2 | 2020-12-07 | French | Compare |
| v3 | 2020-12-14 | English | Compare |
| v4 | 2020-12-14 | French | Compare |
Showing 1 to 4 of 4